Regencell Bioscience
About: Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Employees: 12
0
Funds holding %
of 7,324 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
80% more capital invested
Capital invested by funds: $156K [Q4 2024] → $281K (+$125K) [Q1 2025]
67% more funds holding
Funds holding: 3 [Q4 2024] → 5 (+2) [Q1 2025]
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.17% less ownership
Funds ownership: 0.24% [Q4 2024] → 0.07% (-0.17%) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for RGC.
Financial journalist opinion
Positive
The Motley Fool
4 weeks ago
1 Magnificent Stock-Split Stock to Buy Hand Over Fist in July and 1 to Completely Avoid
Though artificial intelligence (AI) has been the hottest innovation on Wall Street for well over two years, it's not the only trend that's helped power Wall Street's major stock indexes to record-closing highs. Excitement surrounding stock splits in some of the market's most influential businesses has been pivotal in sending the broader market higher.
Positive
The Motley Fool
1 month ago
Prediction: Wall Street's Latest Stock-Split Stock -- Up 60,120% Year-to-Date -- Is Going to Implode
Since the S&P 500's bull market began in October 2022, no trend has provided a bigger lift to equities than the evolution of artificial intelligence (AI). In Sizing the Prize, the analysts at PwC estimated AI would bolster the worldwide economy to the tune of $15.7 trillion come 2030.
Positive
Benzinga
1 month ago
This Chinese Herb Stock Is Now Bigger Than Super Micro And Reddit
Regencell Bioscience Holdings Ltd. RGC, a Hong Kong-based biotech startup with no reported revenue, has gained more than 59,000% in 2025.
Negative
Benzinga
1 month ago
Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
As of June 17, 2025, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Positive
Invezz
1 month ago
This stock with no revenue surges 64,000% in a year: find out why
Regencell Bioscience Holdings, a biotech company focused on herbal medicine, has gained over 400% on Monday and over 64,000% in the past year. This growth in stock price is despite the company not having any revenue so far.
Positive
InvestorPlace
1 year ago
What Is Going on With Regencell Bioscience (RGC) Stock Today?
Little-known drug manufacturer Regencell Bioscience (NASDAQ: RGC ) saw its shares skyrocket on Tuesday on no apparent catalyst. However, it's possible that the exceptionally distinct business profile — specializing in traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders — caught the attention of speculators.
Charts implemented using Lightweight Charts™